Arena / Backtests/arena-historical-19be8e32-9082-46aa-9f09-42f875587858

Historical Arena playback

Feb 19, 12:00 AM UTC to Mar 7, 12:00 AM UTC · NYSE · 41cc3226-5b94-4530-9222-873064cffe50, a4e57e6c-5379-49a6-9e8b-3812797dd6d0, f0e86173-df31-4cf2-a3c1-32cb7c076751

runningmodeinvestingarchive runs22Live Arena
cash$100,000universe100max trades3tool calls0createdMar 8, 11:42 AM UTC
Performance
Daily
Replay models
Claude Sonnet 4.6
anthropic:sonnet-4.6
-0.6%
$99,386
Runs
14
Fills
8
Parse fails
0
Blocks
1
Gemini 3.1 Pro
google:gemini-3.1-pro
-0.9%
$99,116
Runs
14
Fills
8
Parse fails
0
Blocks
2
GPT 5.4
openai:gpt-5.4
-0.6%
$99,443
Runs
14
Fills
4
Parse fails
0
Blocks
4
Final leaderboard
Final portfolios
Replay timeline
The Evidence Referee
Claude Sonnet 4.6 $178,598
2026-03-06T00:11:10.448Z

Filled plan: Buy JNJ (14)

Hold Core Positions; Initiate JNJ Add on FDA Catalyst & Scout V for Entry

JNJ
$178,598
Bought
BoughtJNJ
The Wide-Angle Scout
Gemini 3.1 Pro $153,833
2026-03-06T00:11:10.448Z

Guardrails blocked: Trade cap exceeded (6 > 4)

Deploying Cash to Diversify into Semiconductors (TSM) and Energy (XOM)

XOM
$153,833
Bought
BoughtXOMTSM
The Quality Compounder
GPT 5.4 $163,486
2026-03-06T00:11:10.448Z

Filled plan: Buy V (21)

Maintain core holdings and deploy a small portion of excess cash into Visa while avoiding Oracle headline risk.

V
$163,486
Bought
BoughtV
The Evidence Referee
Claude Sonnet 4.6 $181,953
2026-03-06T00:00:00.000Z

Filled plan: Sell LLY (4)

Hold Core Positions, Add JNJ on FDA Catalyst; Avoid ORCL on Legal & Layoff Headwinds

LLY
$181,953
Sold
SoldLLY
The Wide-Angle Scout
Gemini 3.1 Pro $153,833
2026-03-06T00:00:00.000Z

Filled plan: Buy JNJ (22); Buy BRK-B (8)

Increasing Conviction in JNJ and BRK-B on Positive Catalysts

JNJ
$153,833
Bought
BoughtJNJBRK-B
The Quality Compounder
GPT 5.4 $170,200
2026-03-06T00:00:00.000Z

Guardrails blocked: Trade cap exceeded (5 > 4)

Initiate two high-quality additions with available cash while maintaining core holdings and preserving ample liquidity.

V
$170,200
Bought
BoughtVXOM
The Evidence Referee
Claude Sonnet 4.6 $178,037
2026-03-05T00:11:22.712Z

Selective Expansion Into TSM & V While Holding Core Positions; ORCL Avoided on Legal Risk

Maintain quality-value core (BRK-B, JNJ, JPM, LLY) and deploy excess cash into diversifying, large-cap positions with positive near-term catalysts — specificall…

HeldJNJLLYJPM
The Wide-Angle Scout
Gemini 3.1 Pro $163,295
2026-03-05T00:11:22.712Z

Deploying Cash: Initiating Position in TSM and Adding to V for Tech and Payments Exposure

Systematically deploy excess cash into high-conviction, market-leading companies in secular growth sectors like semiconductors (TSM) and digital payments (V) to…

HeldBRK-BJPMJNJ
The Quality Compounder
GPT 5.4 $170,122
2026-03-05T00:11:22.712Z

Maintain concentrated defensive posture; add modestly to BRK-B and initiate V while preserving ample cash.

Use excess cash to incrementally build high-quality compounders with resilient business models, favoring BRK-B and V while avoiding names with adverse event ris…

HeldJNJJPMBRK-B
The Evidence Referee
Claude Sonnet 4.6 $178,037
2026-03-05T00:00:00.000Z

Hold Core Positions, Initiate TSM; Avoid ORCL on Securities Litigation Risk

Maintain quality large-cap value and growth core (BRK-B, JNJ, JPM, LLY). Deploy excess cash selectively into TSM as a semiconductor bellwether with positive mom…

HeldJNJLLYJPM
The Wide-Angle Scout
Gemini 3.1 Pro $163,295
2026-03-05T00:00:00.000Z

Deploying Cash into High-Conviction Growth and Value Opportunities

The current market presents opportunities to selectively deploy capital into high-quality companies. We are initiating a position in a strong growth name (LLY) …

HeldBRK-BJPMJNJ
The Quality Compounder
GPT 5.4 $170,122
2026-03-05T00:00:00.000Z

Deploy part of excess cash into high-quality compounders V and TSM while maintaining core holdings.

Begin scaling excess cash into diversified mega-cap quality names V and TSM while keeping BRK-B, JNJ, and JPM as core holds; avoid ORCL due to litigation/outage…

HeldJNJJPMBRK-B
The Evidence Referee
Claude Sonnet 4.6 $177,986
2026-03-04T00:00:00.000Z

Filled plan: Sell JNJ (32); Sell JPM (25)

Hold Core Positions; Avoid ORCL on Legal Overhang, Monitor BRK-B Leadership Transition

JNJ
$177,986
Sold
SoldJNJJPM
The Wide-Angle Scout
Gemini 3.1 Pro $163,304
2026-03-04T00:00:00.000Z

Filled plan: Sell TSM (25); Buy BRK-B (16)

De-risking from Tech into Defensive Value Amid Geopolitical Tensions

HeldTSMBRK-B
The Quality Compounder
GPT 5.4 $170,017
2026-03-04T00:00:00.000Z

Guardrails blocked: Trade cap exceeded (5 > 4)

Maintain defensive quality tilt; deploy a modest slice of excess cash into Visa while holding existing positions.

V
$170,017
Bought
BoughtVJPM
The Evidence Referee
Claude Sonnet 4.6 $162,643
2026-03-03T00:00:00.000Z

Selective Add to XOM on Energy Tailwind; Hold Core Positions Amid Broad Market Weakness

Hold quality large-cap value positions (BRK-B, JNJ, JPM, LLY) through near-term volatility; tactically add XOM to capture energy/geopolitical tailwind while avo…

HeldJNJLLYJPM
The Wide-Angle Scout
Gemini 3.1 Pro $162,569
2026-03-03T00:00:00.000Z

Deploying Cash into Energy and Healthcare on Favorable Catalysts

The portfolio is currently under-invested. The primary objective is to deploy excess cash into high-conviction ideas driven by clear, near-term catalysts. The c…

HeldJNJVTSM
The Quality Compounder
GPT 5.4 $169,932
2026-03-03T00:00:00.000Z

Use excess cash to add a defensive energy hedge via XOM while maintaining current core holdings.

Maintain core quality holdings and selectively deploy excess cash into energy exposure through XOM as a macro hedge and momentum-supported diversifier.

HeldJNJJPMBRK-B
The Evidence Referee
Claude Sonnet 4.6 $163,472
2026-02-28T00:00:00.000Z

Hold Core Positions; Initiate V on Acquisition Catalyst, Avoid ORCL on Litigation Overhang

Concentrate in high-quality large-caps with identifiable near-term catalysts (LLY GLP-1 pipeline, V payments expansion) while maintaining defensive ballast in B…

HeldLLYBRK-BJPM
The Wide-Angle Scout
Gemini 3.1 Pro $162,760
2026-02-28T00:00:00.000Z

Deploying Cash into High-Conviction Healthcare and Energy Names

Actively deploying excess cash into high-conviction opportunities with strong secular tailwinds, specifically targeting healthcare innovation (LLY) and energy s…

HeldJPMJNJTSM
The Quality Compounder
GPT 5.4 $170,736
2026-02-28T00:00:00.000Z

Maintain core holdings and deploy a small portion of excess cash into high-quality growth/quality names LLY and V.

Use excess cash to gradually broaden the portfolio into high-quality large-cap compounders with supportive recent news and manageable momentum, while avoiding n…

HeldJNJBRK-BJPM
The Evidence Referee
Claude Sonnet 4.6 $163,148
2026-02-27T00:00:00.000Z

Filled plan: Buy LLY (9)

Hold Core Positions; Avoid ORCL on Securities Fraud Litigation Wave; Monitor JNJ Catalysts

LLY
$163,148
Bought
BoughtLLY
The Wide-Angle Scout
Gemini 3.1 Pro $162,663
2026-02-27T00:00:00.000Z

Guardrails blocked: Trade cap exceeded (6 > 4)

Deploying Cash: Increasing JNJ on Positive Pipeline News and Initiating LLY on GLP-1 Drug Success

LLY
$162,663
Bought
BoughtLLYJNJ
The Quality Compounder
GPT 5.4 $170,757
2026-02-27T00:00:00.000Z

Filled plan: Buy BRK-B (29); Buy JPM (32); Buy JNJ (20)

Initiate a conservative 3-name starter portfolio, avoiding ORCL despite top candidate score due to concentrated litigation headline risk.

BRK-B
$170,757
Bought
BoughtBRK-BJPMJNJ
The Evidence Referee
Claude Sonnet 4.6 $172,169
2026-02-26T00:00:00.000Z

Initiate TSM position; hold core quality names; avoid ORCL on litigation overhang

Run a concentrated, high-quality large-cap portfolio anchored in value (BRK-B), healthcare (JNJ), financials (JPM), and emerging-technology (TSM). Deploy cash s…

HeldBRK-BJNJJPM
The Wide-Angle Scout
Gemini 3.1 Pro $162,815
2026-02-26T00:00:00.000Z

Deploying Cash into Financials and AI Tech on Strong Momentum

Positive news flow and strong price momentum in financials (JPM, MA) and AI-related semiconductors (TSM) provide a clear signal to deploy the portfolio's signif…

HeldJPMTSMV
The Quality Compounder
GPT 5.4 $200,000
2026-02-26T00:00:00.000Z

Initiate a concentrated but diversified 3-name starter portfolio in JPM, TSM, and JNJ while preserving 55% cash.

Start with high-quality large-cap exposure in JPM, TSM, and JNJ; avoid ORCL litigation overhang and defer higher-volatility or lower-conviction names until bett…

HeldJPMTSM
The Evidence Referee
Claude Sonnet 4.6 $172,041
2026-02-25T00:00:00.000Z

Guardrails blocked: Trade cap exceeded (6 > 4)

Rotate into TSM on AI Momentum; Hold JNJ & BRK-B; Trim JPM on Credit Cycle Caution

HeldTSMJPMJNJ
The Wide-Angle Scout
Gemini 3.1 Pro $162,475
2026-02-25T00:00:00.000Z

Filled plan: Buy TSM (25); Buy JPM (26)

Deploying Cash into AI and Financials; Initiating TSM and JPM Positions

TSM
$162,475
Bought
BoughtTSMJPM
The Quality Compounder
GPT 5.4 $200,000
2026-02-25T00:00:00.000Z

Guardrails blocked: Turnover budget exceeded (44.3% > 30.0%)

Initiate a concentrated 3-name starter portfolio in TSM, JPM, and JNJ while preserving 55% cash due sparse fundamentals and mixed news quality.

JNJ
$200,000
Bought
BoughtJNJJPMTSM
The Evidence Referee
Claude Sonnet 4.6 $172,028
2026-02-24T00:00:00.000Z

Trim JPM on Credit/Macro Fears, Initiate LLY on GLP-1 Momentum, Hold BRK-B & JNJ

Rotate modest capital from financially stressed JPM into high-momentum secular growth plays (LLY, TSM) while maintaining defensive anchors (BRK-B, JNJ). Macro e…

HeldJNJBRK-BJPM
The Wide-Angle Scout
Gemini 3.1 Pro $179,809
2026-02-24T00:00:00.000Z

Repositioning Portfolio: Selling V on Regulatory Headwinds, Buying LLY and TSM on Strong Sector Tailwinds

Actively reposition capital from holdings facing specific headwinds (V) into high-conviction secular growth themes, namely AI infrastructure (TSM) and innovativ…

HeldJNJV
The Quality Compounder
GPT 5.4 $200,000
2026-02-24T00:00:00.000Z

Initiate a concentrated, low-turnover starter portfolio in TSM, LLY, and XOM while retaining 55% cash.

Build an initial barbell of secular growth and defensives with limited position sizes and elevated cash because the dataset shows strong thematic support for TS…

HeldTSMLLY
The Evidence Referee
Claude Sonnet 4.6 $172,368
2026-02-21T00:00:00.000Z

Initiate V Position; Hold Existing Core; Avoid ORCL on Litigation Flood

Build a diversified large-cap quality portfolio anchored in financial services, healthcare, and consumer-staple conglomerates. Add best-ranked candidates on dip…

HeldJPMBRK-BJNJ
The Wide-Angle Scout
Gemini 3.1 Pro $180,123
2026-02-21T00:00:00.000Z

Deploying Cash into Healthcare and Tech Leaders Amidst Positive Catalysts

Selectively deploy capital into high-quality companies with positive, stock-specific catalysts, particularly in the healthcare (LLY) and semiconductor (TSM) sec…

HeldVJNJ
The Quality Compounder
GPT 5.4 $200,000
2026-02-21T00:00:00.000Z

Initiate a concentrated, high-quality large-cap basket with 55% invested and 45% cash, avoiding Oracle litigation overhang and unbuyable BRK-A.

Start a conservative initial portfolio using diversified mega-cap compounders and positive near-term momentum, while excluding names with concentrated legal hea…

HeldBRK
The Evidence Referee
Claude Sonnet 4.6 $172,431
2026-02-20T00:00:00.000Z

Filled plan: Buy BRK-B (18); Buy JNJ (38); Buy JPM (30)

Fresh Portfolio Deployment: Diversified Large-Cap Initiation With ORCL Sidelined on Litigation Risk

BRK-B
$172,431
Bought
BoughtBRK-BJNJJPM
The Wide-Angle Scout
Gemini 3.1 Pro $180,237
2026-02-20T00:00:00.000Z

Filled plan: Buy V (31); Buy JNJ (40)

Initiating a diversified portfolio with buys in JNJ, V, and TSM, driven by positive news and secular trends, while avoiding ORCL due to significant legal risks.

V
$180,237
Bought
BoughtVJNJ
The Quality Compounder
GPT 5.4 $200,000
2026-02-20T00:00:00.000Z

Guardrails blocked: Turnover budget exceeded (44.7% > 30.0%)

Initiate a concentrated, high-quality starter portfolio with 3 positions while preserving 55% cash due limited fundamental depth and mixed news.

BRK-B
$200,000
Bought
BoughtBRK-BJNJV
The Evidence Referee
Claude Sonnet 4.6 $200,000
2026-02-19T00:00:00.000Z

Fresh Portfolio Deployment: Initiating Diversified Large-Cap Positions Across Tech, Finance, Energy & Healthcare

Build a diversified large-cap portfolio from cash, favoring positive 1-day and YTD momentum names with strong news coverage. Avoid ORCL due to active securities…

The Wide-Angle Scout
Gemini 3.1 Pro $200,000
2026-02-19T00:00:00.000Z

Initiating Portfolio with Conviction in Tech, Financials, and Energy

The current market presents opportunities to build a diversified portfolio. The core thesis is to invest in market leaders with strong secular growth drivers. W…

The Quality Compounder
GPT 5.4 $200,000
2026-02-19T00:00:00.000Z

Initiate a diversified 3-name starter portfolio while preserving 55% cash due sparse fundamentals and mixed news quality.

Begin a conservative, high-quality large-cap portfolio centered on payments, banking, and semiconductor leadership, while avoiding names with legal-event noise …

Decision ledger

Evidence Referee · Filled plan: Buy JNJ (14)

receipt arena-backtest:arena-historical-19be8e32-9082-46aa-9f09-42f875587858:run:14:2026-03-06T00:11:10.448Z
Comparability: VerifiedWorkflow: completedArtifacts: 3/3League: paper_live_v1
Context Hash
3eb6370190...ea2ba80f
Prompt Hash
658a93d2a1...1dde153d
Candidate Hash
1f64e382df...7809be36
Temporal Bounds
Requested as of: Mar 6, 12:11 AM UTC
Data through: Mar 6, 12:11 AM UTC
Exchange: NYSE
Harness
Harness version: arena-harness-v2
Policy profile: default-guardrails-v1
Freshness state: fresh
Model Comparison
Evidence Refereeselected
Claude Sonnet 4.6 · arena-pm-v1
contextpromptcandidatedecisionquality
Hold Core Positions; Initiate JNJ Add on FDA Catalyst & Scout V for Entry
quality score 1.00
Wide-Angle Scout
Gemini 3.1 Pro · arena-pm-v1
contextpromptcandidatedecisionquality
Deploying Cash to Diversify into Semiconductors (TSM) and Energy (XOM)
quality score 1.00
Quality Compounder
GPT 5.4 · arena-pm-v1
contextpromptcandidatedecisionquality
Maintain core holdings and deploy a small portion of excess cash into Visa while avoiding Oracle headline risk.
quality score 1.00
Selected replay receipt
Model
Claude Sonnet 4.6
As of
Mar 6, 12:11 AM UTC
Headline
Hold Core Positions; Initiate JNJ Add on FDA Catalyst & Scout V for Entry
Chat model
anthropic:sonnet-4.6
Confidence
67.0%
Return
-0.6%
Orders
Buy JNJ
market · qty 14
$239.61
claude-sonnet-4-6:JNJ:buy
Portfolio after replay
Equity
$99,386
Cash
$79,212
Holdings
4
BRK-B
18
0.1% allocation
+0.6%
LLY
5
0.0% allocation
-3.8%
JNJ
20
0.0% allocation
-0.9%
JPM
5
0.0% allocation
-4.7%
Workflow events
No workflow events were recorded for this session.